These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12590236)
21. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Poritz LS; Rowe WA; Koltun WA Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629 [TBL] [Abstract][Full Text] [Related]
22. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]. Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144 [TBL] [Abstract][Full Text] [Related]
23. Massive gastrointestinal bleeding in Crohn's disease: successful control by intra-arterial vasopressin infusion. Mellor JA; Chandler GN; Chapman AH; Irving HC Gut; 1982 Oct; 23(10):872-4. PubMed ID: 6981537 [TBL] [Abstract][Full Text] [Related]
25. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. ten Hove T; van Montfrans C; Peppelenbosch MP; van Deventer SJ Gut; 2002 Feb; 50(2):206-11. PubMed ID: 11788561 [TBL] [Abstract][Full Text] [Related]
27. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ; Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785 [TBL] [Abstract][Full Text] [Related]
28. Crohn's disease and massive lower gastrointestinal bleeding: angiographic appearance and two case reports. McGarrity TJ; Manasse JS; Koch KL; Weidner WA Am J Gastroenterol; 1987 Oct; 82(10):1096-9. PubMed ID: 2821799 [TBL] [Abstract][Full Text] [Related]
29. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease. Kierkus J; Dadalski M; Szymanska E; Oracz G; Wegner A; Gorczewska M; Szymanska S; Woynarowski M; Ryzko J Eur J Gastroenterol Hepatol; 2012 May; 24(5):495-500. PubMed ID: 22387887 [TBL] [Abstract][Full Text] [Related]
30. Severe gastrointestinal bleeding in Crohn's disease. Veroux M; Angriman I; Ruffolo C; Barollo M; Buffone A; Madia C; Caglià P; Fiamingo P; D'Amico D Ann Ital Chir; 2003; 74(2):213-5; discussion 216. PubMed ID: 14577120 [TBL] [Abstract][Full Text] [Related]
31. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. Keating GM; Perry CM BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485 [TBL] [Abstract][Full Text] [Related]
32. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]